Sunday, 5th December 2021

Britain is first to approve Merck COVID-19 antiviral pill

By Guardian Exclusive
06 November 2021   |   12:41 pm
Britain on Thursday (November 4) granted conditional authorization for Drugmaker Merck's COVID-19 pill, molnupiravir, the first pill shown to successfully treat COVID-19. It reduced hospitalizations, and deaths by around 50% in people severely infected with the coronavirus, according to interim clinical trial results announced on October 1. Due to the strong positive results, the Phase 3 trial is being stopped early at the recommendation of an independent group of medical advisers.